Cargando…

Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms

Neurometabolic disorders are hereditary conditions mainly affect the function of the brain and the nervous system. The prevalence of these disorders is 1 in 1,000 live births. Such disorders, at different ages, could manifest as sepsis, hypoglycemia, and other neurologic disorders. Having similar ma...

Descripción completa

Detalles Bibliográficos
Autores principales: KARIMZADEH, Parvaneh, GHOFRANI, Mohammad, NASIRI, Shahram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shahid Beheshti University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468080/
https://www.ncbi.nlm.nih.gov/pubmed/32952579
_version_ 1783578140221636608
author KARIMZADEH, Parvaneh
GHOFRANI, Mohammad
NASIRI, Shahram
author_facet KARIMZADEH, Parvaneh
GHOFRANI, Mohammad
NASIRI, Shahram
author_sort KARIMZADEH, Parvaneh
collection PubMed
description Neurometabolic disorders are hereditary conditions mainly affect the function of the brain and the nervous system. The prevalence of these disorders is 1 in 1,000 live births. Such disorders, at different ages, could manifest as sepsis, hypoglycemia, and other neurologic disorders. Having similar manifestations leads to delayed diagnosis of neurometabolic disorders. A number of neurometabolic disorders have known treatments; however, to prevent long-term complications the key factors are early diagnosis and treatment. Although a large number of neurometabolic diseases have no treatment or cure, the correct and on-time diagnosis before death is important for parents to have plans for prenatal diagnosis. Different diagnostic procedures could be offered to parents, enzymatic procedures, and determining metabolites in plasma, urine, and CSF, and molecular genetic diagnosis. Molecular genetic diagnostic procedures are expensive and could not be offered to all parents. Therefore, we aimed to design algorithms to diagnose neurometabolic disorders according to some frequent and characteristic signs and symptoms. By designing these algorithms and using them properly, we could offer diagnostic enzymatic panels. These enzymatic panels are inexpensive; thereby reducing the financial burden on the parents. Also, having an early diagnosis according to these panels could lead to offering more accurate and less expensive molecular genetic tests.
format Online
Article
Text
id pubmed-7468080
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Shahid Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-74680802020-10-01 Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms KARIMZADEH, Parvaneh GHOFRANI, Mohammad NASIRI, Shahram Iran J Child Neurol Review Article Neurometabolic disorders are hereditary conditions mainly affect the function of the brain and the nervous system. The prevalence of these disorders is 1 in 1,000 live births. Such disorders, at different ages, could manifest as sepsis, hypoglycemia, and other neurologic disorders. Having similar manifestations leads to delayed diagnosis of neurometabolic disorders. A number of neurometabolic disorders have known treatments; however, to prevent long-term complications the key factors are early diagnosis and treatment. Although a large number of neurometabolic diseases have no treatment or cure, the correct and on-time diagnosis before death is important for parents to have plans for prenatal diagnosis. Different diagnostic procedures could be offered to parents, enzymatic procedures, and determining metabolites in plasma, urine, and CSF, and molecular genetic diagnosis. Molecular genetic diagnostic procedures are expensive and could not be offered to all parents. Therefore, we aimed to design algorithms to diagnose neurometabolic disorders according to some frequent and characteristic signs and symptoms. By designing these algorithms and using them properly, we could offer diagnostic enzymatic panels. These enzymatic panels are inexpensive; thereby reducing the financial burden on the parents. Also, having an early diagnosis according to these panels could lead to offering more accurate and less expensive molecular genetic tests. Shahid Beheshti University of Medical Sciences 2020 /pmc/articles/PMC7468080/ /pubmed/32952579 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
KARIMZADEH, Parvaneh
GHOFRANI, Mohammad
NASIRI, Shahram
Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms
title Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms
title_full Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms
title_fullStr Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms
title_full_unstemmed Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms
title_short Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms
title_sort approach to patients with neurometabolic diseases who show characteristic signs and symptoms
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468080/
https://www.ncbi.nlm.nih.gov/pubmed/32952579
work_keys_str_mv AT karimzadehparvaneh approachtopatientswithneurometabolicdiseaseswhoshowcharacteristicsignsandsymptoms
AT ghofranimohammad approachtopatientswithneurometabolicdiseaseswhoshowcharacteristicsignsandsymptoms
AT nasirishahram approachtopatientswithneurometabolicdiseaseswhoshowcharacteristicsignsandsymptoms